- Liver Disease Diagnosis and Treatment
- Diet, Metabolism, and Disease
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolism, Diabetes, and Cancer
- Liver Disease and Transplantation
- Adipokines, Inflammation, and Metabolic Diseases
- Diet and metabolism studies
- Peripheral Artery Disease Management
- Diabetic Foot Ulcer Assessment and Management
- Diabetes Treatment and Management
- Healthcare Systems and Public Health
- Blood Pressure and Hypertension Studies
- Therapeutic Uses of Natural Elements
- Sepsis Diagnosis and Treatment
- Vitamin D Research Studies
- Liver Diseases and Immunity
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Proteins in Food Systems
- Muscle and Compartmental Disorders
- Lipoproteins and Cardiovascular Health
- Vitamin C and Antioxidants Research
- Cancer, Lipids, and Metabolism
- Neurological Disorders and Treatments
Azienda Unita' Sanitaria Locale Di Modena
2010-2024
University of Modena and Reggio Emilia
2005-2021
Universidade Federal do Paraná
2017
Liver fibrosis predicts liver-related and cardiovascular outcomes in chronic liver disease patients. We compared the diagnostic performance of various biomarkers for identifying histological significant/advanced fibrosis. Additionally, correlations such with risk (CVR) scores were evaluated. 173 patients viral hepatitis (157 HCV 16 HBV) 107 a non-alcoholic fatty (NAFLD) consecutively enrolled. Various biomarkers: aspartate aminotransferase (AST) to alanine (ALT) ratio (ARR), AST Platelet...
Background. Nonalcoholic fatty liver disease (NAFLD), the most common chronic disorder worldwide, comprises a spectrum of conditions ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. NASH is associated with an increased risk hepatocellular carcinoma (HCC) cardiometabolic disease. Insulin resistance (IR) underlying pathogenic mechanism for NAFLD, presence which in turn, strong predictor development metabolic disorders. Hence, therapy NAFLD insulin-sensitizing...
<title>Abstract</title> <bold>Introduction: </bold>Few data are available relatively to the adherence treatment guidelines in individuals with type 2 diabetes mellitus (T2DM) admitted Internal Medicine Wards (IMW) while no information is possible efficacy of an educational intervention aimed at implementing this setting. <bold>Methods: </bold>To explore and relative impact on glycemic control subjects T2DM hospitalized IMW before after intervention, we conducted a 3-phase,...
Background. Nonalcoholic fatty liver disease (NAFLD), the most common chronic disorder worldwide, comprises a spectrum of conditions ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. NASH is associated with an increased risk hepatocellular carcinoma (HCC) cardiometabolic disease. Insulin resistance (IR) underlying pathogenic mechanism for NAFLD, presence which in turn, strong predictor development metabolic disorders. Hence, therapy NAFLD insulin-sensitizing...
Fever often occurs in cancer patients and the possibility of having a reliable marker for differential etiological diagnosis is desirable. The aim this study was to investigate eligibility use procalcitonin (PCT) hemato-oncological fever. We prospectively enrolled 98 divided them into two groups: those with active disease non-active disease. Procalcitonin dosed at Time 0 (recruitment) onset On enrollment, PCT values were 0.1 ng/mL 83% disease, lower than 0.5 23%, which usually considered not...
Aim: Diabetic foot syndrome (DFS) is a complication of diabetes in which the presence infections, ulceration and/or destruction deep tissue associated with neuropathy, peripheral atherosclerosis and comorbidity affect prognosis, need for limb amputation quality life. Purpose present study to report features patients acute DFS admitted our Foot Unit tertiary Center 2019. Methods: In all admitted, approach was performed through multidisciplinary team (Diabetic Care Team) described specific...